Evaluating the potential bioactivity of a novel compound ER1626.

Article English OPEN
Wang, Lijun; Zeng, Yanyan; Wang, Tianling; Liu, Hongyi; Xiao, Hong; Xiang, Hua;
  • Publisher: Public Library of Science (PLoS)
  • Journal: PLoS ONE,volume 9,issue 1 (issn: 1932-6203, eissn: 1932-6203)
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.1371/journal.pone.0086509, pmc: PMC3903524
  • Subject: Cancer Treatment | Research Article | Biology | Molecular Cell Biology | Pharmacodynamics | Antiangiogenesis Therapy | Breast Cancer | Medicine | Drug Research and Development | Basic Cancer Research | Oncology | Q | R | Drug Discovery | Drugs and Devices | Biochemistry | Obstetrics and Gynecology | Science
    mesheuropmc: skin and connective tissue diseases

Background ER1626, a novel compound, is a derivate of indeno-isoquinoline ketone. This study was designed to evaluate the biological activity and potential anti-tumor mechanism of ER1626. Method MTT assay, scratch assay and flow cytometry were used to determine cell pro... View more
Share - Bookmark